15/05/2014 - 17:45
Treatment with canagliflozin was associated with significant weight loss as well as improvements in glycemic control, when compared with placebo in a 26-week, phase III study of nearly 600...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology